Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

A new compound shows promise as a topical treatment for hair loss.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Finasteride helps reduce heart enlargement in heart failure patients.

Forsythiaside A helps reduce brain damage from lack of blood flow by activating certain protective pathways.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Tamsulosin increases the risk of floppy iris syndrome during cataract surgery.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Hyaluronate fragments can help reverse skin thinning by working with the CD44 receptor.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Golvatinib shows promise as a treatment for Omicron in elderly patients.